MINK1 rs2806689: Genetic Association and Keratoconus Risk
rs2806689 is a single nucleotide polymorphism located in proximity to the MINK1 gene that has been identified through genome-wide association studies. Research indicates that the minor allele at this locus is statistically associated with a moderately reduced susceptibility to keratoconus, a progressive eye condition affecting corneal structure. While this variant highlights the role of developmental cell signaling pathways in ocular integrity, it represents only one small component of overall visual health.
What each genotype means
Typical keratoconus susceptibility
You carry two copies of the common reference allele at this locus in the MINK1 gene region. In genome-wide association studies, this baseline genotype does not confer the protective effect against keratoconus linked to the minor allele. Your risk for progressive corneal thinning aligns with baseline population factors and family history.
Carried by approximately 40% to 45% of individuals of European ancestry, and common across other global populations.
Moderately reduced keratoconus susceptibility
You carry one copy of the protective T allele at rs2806689 near the MINK1 gene. Large-scale genetic studies associate each copy of this allele with a modest reduction in the risk of developing keratoconus, likely mediated through altered WNT signaling and corneal structural integrity. Overall eye health remains heavily influenced by a combination of other genetic markers and lifestyle factors such as chronic eye rubbing.
Carried by roughly 45% of individuals of European descent.
Reduced keratoconus susceptibility
You carry two copies of the protective minor T allele at rs2806689 in the MINK1 locus. Research indicates that inheriting two copies of this variant is associated with the strongest relative reduction in keratoconus susceptibility among the genotypes at this position. While statistically protective across studied European cohorts, it does not completely eliminate the possibility of developing corneal disorders.
Found in roughly 10% to 15% of individuals of European ancestry.
Genetic Location and Variant Details
The single nucleotide polymorphism rs2806689 is an intergenic or non-coding regulatory variant mapped near the MINK1 locus on human chromosome 17. Single nucleotide polymorphisms, or SNPs, represent single base-pair variations in the genomic sequence that occur commonly throughout the human population. In dbSNP, rs2806689 commonly features a C and T diallelic state. Because rs2806689 is situated outside the protein-coding exons of MINK1, it does not alter the primary amino acid sequence of the resulting enzyme. Instead, genomic annotation studies suggest it resides in a chromosomal regulatory landscape that may influence the expression or transcriptional activity of nearby genes in ocular and connective tissues.
Biological Role of the MINK1 Gene
The MINK1 gene encodes Misshapen-like kinase 1, an enzyme belonging to the germinal center kinase family and the broader STE20 group of serine/threonine protein kinases. MINK1 is involved in cytoskeletal organization, cell adhesion, cellular motility, and non-canonical WNT signaling pathways. These cellular mechanisms are essential for establishing normal tissue architecture and maintaining mechanical resilience in structures exposed to physical tension. In the eye, proper cellular signaling and extracellular matrix regulation are critical for maintaining the stability, transparency, and curved dome shape of the cornea. Computational gene prioritization models analyzing corneal disorders have identified MINK1 as a high-confidence candidate gene due to its integration with cellular pathways essential for corneal structural homeostasis.
Research Link to Keratoconus
Keratoconus is an ocular disorder characterized by progressive thinning, weakening, and conical bulging of the clear front surface of the eye, often resulting in distorted vision and astigmatism. A comprehensive meta-analysis of genome-wide association data published in 2024 evaluated independent European case-control cohorts and identified rs2806689 as a lead genome-wide association signal for keratoconus. Researchers observed a per-allele odds ratio of approximately 0.88 (p = 1.71E-08), indicating that the minor allele is associated with a statistically significant reduction in disease susceptibility. Because the observed odds ratio represents a modest effect, rs2806689 behaves as a moderate-effect susceptibility modifier rather than a deterministic single-gene switch.
Ancestry and Population Frequencies
Allele frequencies for rs2806689 vary across global geographic groups, an important consideration when interpreting population-based genetic studies. In populations of European descent, where the primary discovery and validation cohorts for keratoconus association studies were examined, the minor allele frequency is approximately 0.35. Because the statistical association was established primarily in European sample groups, the predictive value and effect size of this locus may differ in other ancestral backgrounds due to variations in linkage disequilibrium and background genetic architecture. Comprehensive population databases such as gnomAD track these frequency disparities to help researchers place multi-ancestry risk architectures in appropriate context.
Clinical Perspective and Practical Limitations
While discovering an association between rs2806689 and keratoconus enhances our molecular understanding of corneal biology, this information cannot be used in isolation to diagnose, treat, or rule out eye disease. Keratoconus is a complex multifactorial condition influenced by hundreds of genetic variants of small effect, alongside critical environmental and behavioral exposures such as chronic eye rubbing and ocular allergies. Having a genotype associated with lower statistical odds does not make an individual immune to developing corneal thinning. Anyone experiencing visual distortion, progressive astigmatism, or frequent changes in spectacle prescriptions should seek clinical evaluation, including corneal topography, from a licensed optometrist or ophthalmologist.
How common is this variant?
The minor allele frequency for rs2806689 is approximately 0.35 across populations of European ancestry, meaning both heterozygous and homozygous genotypes are commonly observed in these cohorts.
Frequently asked questions
What is the rs2806689 variant?
rs2806689 is a common single nucleotide polymorphism located on chromosome 17 near the MINK1 gene. It has been identified in genome-wide association research as a marker linked to variations in corneal structure and keratoconus risk.
Does having rs2806689 mean I will not get keratoconus?
No. While the minor allele is associated with a lower statistical probability of developing the condition, it provides only a modest reduction in relative odds. Keratoconus is a complex disorder influenced by many genetic loci as well as physical factors like vigorous eye rubbing.
How does MINK1 affect eye health?
The MINK1 gene provides instructions for a kinase enzyme involved in cell movement, structural organization, and WNT signaling. These pathways are thought to help maintain the regular cell matrix and biomechanical strength of the corneal stroma.
Can I use this genetic result to make medical decisions?
No, standalone consumer genetic markers are not diagnostic tools and should not alter your personal eye care routine. Routine comprehensive eye exams with corneal topography remain the medical gold standard for detecting and managing structural corneal diseases.
Sources & further reading
Educational information only, last refreshed 9/11/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2806689?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29